OKKO Health raises £2m in pre seed funding led by Dieter von Holtzbrinck Ventures to support German market entry.
The pre seed round was led by Dieter von Holtzbrinck Ventures to fund the rollout of sight monitoring technology in Germany.
OKKO Health develops digital health technology for monitoring visual function through mobile games. The platform helps clinicians track patient conditions between hospital visits.
OKKO Health has secured £2m in a pre seed financing round led by Dieter von Holtzbrinck Ventures. The capital will be deployed to facilitate the company entry into the German healthcare market, supporting the launch of its remote eye monitoring application and gathering necessary market evidence for national reimbursement.
Founded in 2018, the Bristol headquartered company has created an interactive smartphone game that allows patients to track changes in visual acuity at home. The technology aims to provide early warning signals for clinical intervention in conditions like macular degeneration, shifting towards precision ophthalmology.
From the founder
"This funding will support an important foothold in the German healthcare market, a key step in our global growth. It brings us closer to our vision to get predictive eye health care into the hands of people worldwide, and protect our most valuable sense."
Stephanie Campbell
CEO at OKKO Health
Investor perspective
"OKKO doesn’t simply replicate the eye chart on a smartphone, it’s a whole new way of measuring sight. And the team has shown excellent traction to date, partly testament to its clinical experience. OKKO’s founder, Dr. Stephanie Campbell, has both clinical and vision science expertise, and this gives her deep, first-hand, market understanding which is hugely valuable in the digital health space."
Fabian von Trotha
Dieter von Holtzbrinck Ventures
Use of funds
- 01Expand into international markets
Investors
Categories
About the company
OKKO Health
OKKO Health develops a mobile game app that allows patients to self-monitor eye conditions between clinical appointments.